Start here if you're new
what it is
NHC runs nursing homes, senior housing, behavioral hospitals, and home-care programs for older patients.
how it gets paid
Last year Nhc made $1.5B in revenue. Skilled nursing facilities was the main engine at $0.92B, or 60% of sales.
why it's growing
Revenue grew 16.1% last year. SEC figures in the prompt show latest-quarter revenue up 196% vs. prior year and EPS up 144%.
what just happened
The quarter looked huge, with revenue at $1.1B and EPS at $6.10 in the SEC data, but other sources show a messier print.
At a glance
B++ balance sheet — above average — nothing keeping you up at night
35/100 earnings predictability — expect surprises
26.1x trailing p/e — priced about right
1.6% dividend yield — cash in your pocket every quarter
9.4% return on capital — nothing to write home about
xvary composite: 59/100 — below average
What they do
NHC runs nursing homes, senior housing, behavioral hospitals, and home-care programs for older patients.
Elder care is local, regulated, and hard to build from scratch. NHC already has 72 skilled nursing facilities and 24 assisted living facilities, so your alternative is building trust one license at a time. That footprint matters because referrals follow existing beds, staff, and state approvals.
How they make money
$1.5B
annual revenue · their business grew +16.1% last year
Skilled nursing facilities
$0.92B
Assisted living facilities
$0.31B
Home care and hospice
$0.20B
Independent living facilities
$0.05B
Behavioral health hospitals
$0.04B
The products that matter
facility-based senior care
Inpatient Services
$1.3B · 87% of shown segment revenue
This is the center of gravity. Q3 2025 revenue was $331.3M versus $340.2M from a year ago, which tells you the core business can flatten even when the annual headline still looks fine.
core driver
at-home end-of-life and care services
Homecare & Hospice
$205M · $51.4M in q3 2025
This segment is smaller, but it matters because it expands care beyond the facility walls. At $205M annually, it adds diversification, not a full second engine.
smaller growth lane
outsourced facility support
Management & Financial Services
11 managed · 14 served
NHC manages 11 facilities and provides accounting for 14 others. That's a fee stream with less capital intensity, but the page does not show it large enough to move the whole stock on its own.
fee income
Key numbers
26.1x
trailing p/e
Price-to-earnings ratio → how many years of profit you are paying for → you are paying a growth-stock price for a slow-grower.
10.1%
operating margin
Operating margin → profit after running the business → NHC keeps about 10 cents from each revenue dollar before interest and taxes.
$66M
long-term debt
Long-term debt → money owed over many years → at 3% of capital, the balance sheet has more cushion than many care-facility peers.
9.4%
return on capital
Return on capital → profit earned on the money tied up in the business → decent, but not high enough to justify any price.
Financial health
B++
strength
- balance sheet grade B++ — above average financial health
- risk rank 3 — safer than 50% of stocks
- price stability 75 / 100
- long-term debt $66M (3% of capital)
B++ — functional but not a standout on the balance sheet.
Total return vs. market
Return history isn't available for NHC right now.
source: institutional data · return history unavailable
What just happened
beat estimates
The quarter looked huge, with revenue at $1.1B and EPS at $6.10 in the SEC data, but other sources show a messier print.
SEC figures in the prompt show latest-quarter revenue up 196% vs. prior year and EPS up 144%. Yahoo Finance shows last earnings EPS at $2.51, so you should anchor on the cleaner annual numbers: $1.5B revenue and FY2024 EPS of $6.53.
$1.1B
revenue
$6.10
eps
10.1%
operating margin
the number that mattered
The real tell is annual revenue of $1.5B, up 16.1%, because that says demand held up across the care network even as quarterly reporting looks noisy.
source: SEC filing data in prompt, 2026
Get this snapshot in your inbox
This page, delivered free — plus weekly updates when the numbers change. plain english, no spam.
weekly updates
earnings alerts
plain english
no spam
What could go wrong
the main risk here is medicare and medicaid reimbursement pressure. That is company-specific because 95–97% of NHC's revenue is tied to those payment streams.
med
reimbursement rates move against you
Most of the revenue base depends on government payors. Management does not control rate resets, and shareholders do not get a vote.
A 5% rate cut would reduce annual revenue by about $75M. That is real pressure on a $2B business.
med
the core inpatient engine slows
Inpatient Services is still the whole story in practice. Q3 2025 revenue was $331.3M versus $340.2M from a year ago, which shows the main segment does not need to collapse to become a problem.
When 87% of shown segment revenue comes from one lane, even a flat quarter changes how the market reads the stock.
med
valuation compresses before operations improve
The stock trades at 26.1x trailing earnings while return on capital is 9.4% and predictability is 35/100. That's a multiple that assumes more order than the current data shows.
You can lose on the multiple even if the business stays merely okay.
med
the smaller segments stay too small
Homecare & Hospice is a useful diversification lane at $205M, but it is still much smaller than the $1.3B inpatient base. Management & Financial Services adds fees, not a full strategic reset.
If the core facility business stumbles, the side businesses are not big enough to absorb the hit.
A 5% reimbursement cut is about $75M of revenue pressure, and the smaller $205M homecare business is not large enough to bail out weakness in the $1.3B inpatient base.
source: institutional data · regulatory filings · risk analysis
Pay attention to
calendar
next earnings update
The next report matters because a 35/100 predictability score leaves room for ugly surprises. You are looking for cleaner segment trends, not management poetry.
metric
inpatient services revenue
This is still the stock's center of gravity. Q3 2025 was $331.3M versus $340.2M from a year ago. If that line keeps slipping, the rest of the page barely matters.
risk
reimbursement headlines
Because 95–97% of revenue is tied to Medicare and Medicaid, policy changes deserve more of your attention than day-to-day price action.
trend
predictability improving from the 30s
If earnings predictability stays stuck at 35/100, the market will keep treating NHC like a quarter-to-quarter story. You want that number moving up, not sideways.
Analyst rankings
short-term outlook
mixed
coverage looks thin. in human-speak, there is no strong consensus telling you this is an obvious near-term winner.
risk profile
moderate
The balance sheet is decent, but reimbursement exposure keeps this from being a sleepy healthcare stock.
chart momentum
stock-specific
This name is more likely to trade on reimbursement, utilization, and facility execution than on target-price revisions.
earnings predictability
35/100
That's a low score. Translation: you should expect quarters that read choppier than the business pitch.
source: institutional data
Institutional activity
institutional ownership data for NHC is being compiled.
source: institutional data
Price targets
3-5 year target range
n/a
n/a
$161
current price
n/a
target midpoint · n/a from current
Want the deeper analysis?
The full deep dive: dcf model, scenario analysis, competitive moat breakdown, and quarterly tracking — everything on this page, taken further.
see plans from $5/moThe deep dive